Current role and future direction of osimertinib in epidermal growth factor receptor-mutant non-small cell lung cancer

Samankaltaisia teoksia

• First-line osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer
  Tekijä: Jeong, Byeong-Ho, et al.
  Julkaistu: (2018)
• The role of osimertinib in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer
  Tekijä: Liam, Chong-Kin
  Julkaistu: (2019)
• Osimertinib for EGFR-mutant non-small cell lung cancer: place in therapy and future perspectives
  Tekijä: Ricciuti, Biagio
  Julkaistu: (2019)
• Central nervous system activity of first-line osimertinib in epidermal growth factor receptor-mutant advanced non-small cell lung cancer
  Tekijä: Liam, Chong-Kin
  Julkaistu: (2019)
• The impact of age and performance status on the efficacy of osimertinib in patients with EGFR T790M-positive non-small cell lung cancer
  Tekijä: Gil, Hyun-Il, et al.
  Julkaistu: (2020)